Coexpression cluster:C401
From FANTOM5_SSTAR
Full id: C401_Cardiac_pineal_occipital_globus_Hepatocyte_Osteoblast_hippocampus
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0008015 | blood circulation | 0.000419219703150404 |
GO:0003013 | circulatory system process | 0.000419219703150404 |
GO:0003008 | system process | 0.000419219703150404 |
GO:0032501 | multicellular organismal process | 0.00108973671533384 |
GO:0009653 | anatomical structure morphogenesis | 0.00198778520051913 |
GO:0009887 | organ morphogenesis | 0.00231233490456949 |
GO:0031252 | leading edge | 0.00450041737435283 |
GO:0042157 | lipoprotein metabolic process | 0.00536433127423976 |
GO:0048731 | system development | 0.00540490358575841 |
GO:0005319 | lipid transporter activity | 0.00540490358575841 |
GO:0043495 | protein anchor | 0.00540490358575841 |
GO:0050749 | apolipoprotein E receptor binding | 0.00540490358575841 |
GO:0005586 | collagen type III | 0.00540490358575841 |
GO:0006869 | lipid transport | 0.00780639350888681 |
GO:0048856 | anatomical structure development | 0.00780639350888681 |
GO:0048156 | tau protein binding | 0.00780639350888681 |
GO:0030220 | platelet formation | 0.00780639350888681 |
GO:0005826 | contractile ring | 0.00780639350888681 |
GO:0031232 | extrinsic to external side of plasma membrane | 0.00961154805122228 |
GO:0032154 | cleavage furrow | 0.00961154805122228 |
GO:0044421 | extracellular region part | 0.00961154805122228 |
GO:0007275 | multicellular organismal development | 0.00961154805122228 |
GO:0032153 | cell division site | 0.0108069435902759 |
GO:0043534 | blood vessel endothelial cell migration | 0.0108069435902759 |
GO:0030224 | monocyte differentiation | 0.0108069435902759 |
GO:0032155 | cell division site part | 0.0108069435902759 |
GO:0050793 | regulation of developmental process | 0.0124559386413484 |
GO:0048513 | organ development | 0.014530909143863 |
GO:0033344 | cholesterol efflux | 0.014530909143863 |
GO:0010092 | specification of organ identity | 0.0147832261379335 |
GO:0001759 | induction of an organ | 0.0147832261379335 |
GO:0050877 | neurological system process | 0.0147832261379335 |
GO:0031128 | induction | 0.0147832261379335 |
GO:0045168 | cell-cell signaling during cell fate commitment | 0.0147832261379335 |
GO:0042627 | chylomicron | 0.0147832261379335 |
GO:0031532 | actin cytoskeleton reorganization | 0.0147832261379335 |
GO:0050750 | low-density lipoprotein receptor binding | 0.0147832261379335 |
GO:0045471 | response to ethanol | 0.0147832261379335 |
GO:0042995 | cell projection | 0.0150458835817061 |
GO:0006707 | cholesterol catabolic process | 0.0150458835817061 |
GO:0016127 | sterol catabolic process | 0.0150458835817061 |
GO:0048168 | regulation of neuronal synaptic plasticity | 0.0150458835817061 |
GO:0001540 | beta-amyloid binding | 0.0163274240036984 |
GO:0032432 | actin filament bundle | 0.0164301906435854 |
GO:0005583 | fibrillar collagen | 0.0164301906435854 |
GO:0017127 | cholesterol transporter activity | 0.0164301906435854 |
GO:0001725 | stress fiber | 0.0164301906435854 |
GO:0007271 | synaptic transmission, cholinergic | 0.0168469259304954 |
GO:0043542 | endothelial cell migration | 0.0168469259304954 |
GO:0030516 | regulation of axon extension | 0.0168469259304954 |
GO:0032502 | developmental process | 0.0168974304224498 |
GO:0015248 | sterol transporter activity | 0.0168974304224498 |
GO:0033619 | membrane protein proteolysis | 0.0168974304224498 |
GO:0006509 | membrane protein ectodomain proteolysis | 0.0168974304224498 |
GO:0042632 | cholesterol homeostasis | 0.0181532546775641 |
GO:0000146 | microfilament motor activity | 0.0181532546775641 |
GO:0055092 | sterol homeostasis | 0.0181532546775641 |
GO:0005578 | proteinaceous extracellular matrix | 0.0181532546775641 |
GO:0030048 | actin filament-based movement | 0.0186374556962015 |
GO:0048167 | regulation of synaptic plasticity | 0.0186374556962015 |
GO:0006706 | steroid catabolic process | 0.0186374556962015 |
GO:0051262 | protein tetramerization | 0.0186374556962015 |
GO:0048675 | axon extension | 0.0186374556962015 |
GO:0055088 | lipid homeostasis | 0.0186374556962015 |
GO:0015918 | sterol transport | 0.0188485102725415 |
GO:0050803 | regulation of synapse structure and activity | 0.0188485102725415 |
GO:0030301 | cholesterol transport | 0.0188485102725415 |
GO:0042311 | vasodilation | 0.0190151302149179 |
GO:0001657 | ureteric bud development | 0.0190151302149179 |
GO:0032989 | cellular structure morphogenesis | 0.0190151302149179 |
GO:0000902 | cell morphogenesis | 0.0190151302149179 |
GO:0048869 | cellular developmental process | 0.02099236082885 |
GO:0030154 | cell differentiation | 0.02099236082885 |
GO:0043407 | negative regulation of MAP kinase activity | 0.0224387791240267 |
GO:0001656 | metanephros development | 0.0224387791240267 |
GO:0006810 | transport | 0.0231720613631511 |
GO:0050770 | regulation of axonogenesis | 0.0236731024067316 |
GO:0000302 | response to reactive oxygen species | 0.0242662892719579 |
GO:0051234 | establishment of localization | 0.0243968322304056 |
GO:0006958 | complement activation, classical pathway | 0.0245337484807454 |
GO:0008034 | lipoprotein binding | 0.0250940349738294 |
GO:0002573 | myeloid leukocyte differentiation | 0.0252749891205452 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 0.0252749891205452 |
GO:0008092 | cytoskeletal protein binding | 0.0252749891205452 |
GO:0050900 | leukocyte migration | 0.025557807841472 |
GO:0000910 | cytokinesis | 0.0273925062569107 |
GO:0007267 | cell-cell signaling | 0.0273925062569107 |
GO:0005737 | cytoplasm | 0.0281269809152259 |
GO:0001822 | kidney development | 0.0283335906023209 |
GO:0051179 | localization | 0.0284490305427894 |
GO:0050767 | regulation of neurogenesis | 0.0284490305427894 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0284490305427894 |
GO:0002541 | activation of plasma proteins during acute inflammatory response | 0.0284490305427894 |
GO:0030027 | lamellipodium | 0.0284490305427894 |
GO:0006956 | complement activation | 0.0284490305427894 |
GO:0051015 | actin filament binding | 0.0284490305427894 |
GO:0001655 | urogenital system development | 0.0288275807188739 |
GO:0022603 | regulation of anatomical structure morphogenesis | 0.0288275807188739 |
GO:0022604 | regulation of cell morphogenesis | 0.0288275807188739 |
GO:0035150 | regulation of tube size | 0.0288275807188739 |
GO:0008360 | regulation of cell shape | 0.0288275807188739 |
GO:0050880 | regulation of blood vessel size | 0.0288275807188739 |
GO:0001726 | ruffle | 0.0289438204544674 |
GO:0003018 | vascular process in circulatory system | 0.0289438204544674 |
GO:0007611 | learning and/or memory | 0.0293322770254043 |
GO:0044448 | cell cortex part | 0.0297132878901067 |
GO:0044242 | cellular lipid catabolic process | 0.031389652619269 |
GO:0019897 | extrinsic to plasma membrane | 0.0320919334640991 |
GO:0009897 | external side of plasma membrane | 0.0320919334640991 |
GO:0016064 | immunoglobulin mediated immune response | 0.03243332931013 |
GO:0019724 | B cell mediated immunity | 0.0327684628976585 |
GO:0005581 | collagen | 0.0337190066691928 |
GO:0042158 | lipoprotein biosynthetic process | 0.0337379382312679 |
GO:0008305 | integrin complex | 0.0337379382312679 |
GO:0006469 | negative regulation of protein kinase activity | 0.0343558659292324 |
GO:0033673 | negative regulation of kinase activity | 0.0343558659292324 |
GO:0051348 | negative regulation of transferase activity | 0.0352511684169105 |
GO:0051259 | protein oligomerization | 0.0364113765646222 |
GO:0010033 | response to organic substance | 0.0364113765646222 |
GO:0005938 | cell cortex | 0.0372661420881728 |
GO:0046907 | intracellular transport | 0.0387880511005239 |
GO:0045165 | cell fate commitment | 0.0403088713670378 |
GO:0002253 | activation of immune response | 0.0403088713670378 |
GO:0002449 | lymphocyte mediated immunity | 0.0403603889076714 |
GO:0006629 | lipid metabolic process | 0.0403603889076714 |
GO:0007600 | sensory perception | 0.0403603889076714 |
GO:0065008 | regulation of biological quality | 0.0403603889076714 |
GO:0006959 | humoral immune response | 0.0404946883957359 |
GO:0008201 | heparin binding | 0.0404946883957359 |
GO:0002250 | adaptive immune response | 0.0404946883957359 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0404946883957359 |
GO:0030099 | myeloid cell differentiation | 0.0406227123295673 |
GO:0002443 | leukocyte mediated immunity | 0.0406227123295673 |
GO:0008203 | cholesterol metabolic process | 0.0406227123295673 |
GO:0002526 | acute inflammatory response | 0.0408351457951511 |
GO:0044267 | cellular protein metabolic process | 0.0420603796506103 |
GO:0035239 | tube morphogenesis | 0.042424566568245 |
GO:0050778 | positive regulation of immune response | 0.042424566568245 |
GO:0044260 | cellular macromolecule metabolic process | 0.042424566568245 |
GO:0007229 | integrin-mediated signaling pathway | 0.042424566568245 |
GO:0002684 | positive regulation of immune system process | 0.042424566568245 |
GO:0003002 | regionalization | 0.042424566568245 |
GO:0043086 | negative regulation of catalytic activity | 0.042424566568245 |
GO:0002521 | leukocyte differentiation | 0.0434321415613147 |
GO:0048518 | positive regulation of biological process | 0.0434321415613147 |
GO:0043405 | regulation of MAP kinase activity | 0.0443950312545569 |
GO:0016125 | sterol metabolic process | 0.044563210610377 |
GO:0051649 | establishment of cellular localization | 0.0453248758207287 |
GO:0019538 | protein metabolic process | 0.0454877976580822 |
GO:0050776 | regulation of immune response | 0.0455142610194365 |
GO:0007596 | blood coagulation | 0.0458239430195316 |
GO:0002682 | regulation of immune system process | 0.0458239430195316 |
GO:0051641 | cellular localization | 0.0459814820448974 |
GO:0050817 | coagulation | 0.0461252636618405 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0468607423454333 |
GO:0007599 | hemostasis | 0.0468607423454333 |
GO:0019898 | extrinsic to membrane | 0.0471405369067976 |
GO:0016459 | myosin complex | 0.0471405369067976 |
GO:0043235 | receptor complex | 0.0475466257239393 |
GO:0002252 | immune effector process | 0.0475466257239393 |
GO:0005539 | glycosaminoglycan binding | 0.0475466257239393 |
GO:0007409 | axonogenesis | 0.0483130591651719 |
GO:0045087 | innate immune response | 0.0483130591651719 |
GO:0050789 | regulation of biological process | 0.0483130591651719 |
GO:0055074 | calcium ion homeostasis | 0.0483130591651719 |
GO:0006874 | cellular calcium ion homeostasis | 0.0483130591651719 |
GO:0030247 | polysaccharide binding | 0.0483130591651719 |
GO:0035295 | tube development | 0.048435221358892 |
GO:0006950 | response to stress | 0.0485090286102478 |
GO:0048667 | neuron morphogenesis during differentiation | 0.0485090286102478 |
GO:0006979 | response to oxidative stress | 0.0485090286102478 |
GO:0048812 | neurite morphogenesis | 0.0485090286102478 |
GO:0006875 | cellular metal ion homeostasis | 0.0488564508901125 |
GO:0055065 | metal ion homeostasis | 0.0488564508901125 |
GO:0005201 | extracellular matrix structural constituent | 0.0488564508901125 |
GO:0007389 | pattern specification process | 0.0489694878069881 |
GO:0050878 | regulation of body fluid levels | 0.049081178617439 |
GO:0000904 | cellular morphogenesis during differentiation | 0.0491915460187666 |
GO:0001871 | pattern binding | 0.0493006122010687 |
GO:0001525 | angiogenesis | 0.0497900101460195 |
GO:0044420 | extracellular matrix part | 0.0498271677129881 |
GO:0042060 | wound healing | 0.0498271677129881 |
GO:0050954 | sensory perception of mechanical stimulus | 0.0498271677129881 |
GO:0007605 | sensory perception of sound | 0.0498271677129881 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.00551548 |
MA0004.1 | 0.122847 |
MA0006.1 | 0.180714 |
MA0007.1 | 0.36188 |
MA0009.1 | 0.46676 |
MA0014.1 | 0.000721098 |
MA0017.1 | 0.226532 |
MA0019.1 | 1.16376 |
MA0024.1 | 0.378349 |
MA0025.1 | 0.584598 |
MA0027.1 | 2.02165 |
MA0028.1 | 0.0539336 |
MA0029.1 | 1.02123 |
MA0030.1 | 0.384823 |
MA0031.1 | 0.33249 |
MA0038.1 | 0.546283 |
MA0040.1 | 0.399176 |
MA0041.1 | 0.133492 |
MA0042.1 | 0.369454 |
MA0043.1 | 1.17884 |
MA0046.1 | 0.457379 |
MA0048.1 | 0.217815 |
MA0050.1 | 0.370723 |
MA0051.1 | 0.183217 |
MA0052.1 | 0.402401 |
MA0055.1 | 0.389286 |
MA0056.1 | 0 |
MA0057.1 | 0.103816 |
MA0058.1 | 0.0742284 |
MA0059.1 | 0.54521 |
MA0060.1 | 0.0152409 |
MA0061.1 | 0.143203 |
MA0063.1 | 0 |
MA0066.1 | 0.546967 |
MA0067.1 | 0.753856 |
MA0068.1 | 0.361473 |
MA0069.1 | 0.454067 |
MA0070.1 | 0.44448 |
MA0071.1 | 0.160989 |
MA0072.1 | 0.44064 |
MA0073.1 | 0.0574575 |
MA0074.1 | 0.182721 |
MA0076.1 | 0.0815705 |
MA0077.1 | 0.434073 |
MA0078.1 | 0.252504 |
MA0081.1 | 0.927903 |
MA0083.1 | 0.473254 |
MA0084.1 | 0.931415 |
MA0087.1 | 0.438554 |
MA0088.1 | 0.0842883 |
MA0089.1 | 0 |
MA0090.1 | 1.53723 |
MA0091.1 | 0.124326 |
MA0092.1 | 0.338625 |
MA0093.1 | 0.0490184 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.568627 |
MA0101.1 | 0.187837 |
MA0103.1 | 0.386056 |
MA0105.1 | 0.00962152 |
MA0106.1 | 0.61335 |
MA0107.1 | 0.112226 |
MA0108.2 | 0.330055 |
MA0109.1 | 0 |
MA0111.1 | 0.651585 |
MA0113.1 | 0.225587 |
MA0114.1 | 0.262046 |
MA0115.1 | 0.682809 |
MA0116.1 | 0.0276251 |
MA0117.1 | 0.499451 |
MA0119.1 | 0.236164 |
MA0122.1 | 0.522217 |
MA0124.1 | 0.644657 |
MA0125.1 | 0.568516 |
MA0130.1 | 0 |
MA0131.1 | 0.26595 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.493123 |
MA0136.1 | 0.190708 |
MA0139.1 | 0.0450422 |
MA0140.1 | 0.48101 |
MA0141.1 | 0.54121 |
MA0142.1 | 0.828623 |
MA0143.1 | 0.640828 |
MA0144.1 | 0.448274 |
MA0145.1 | 0.104585 |
MA0146.1 | 0.465657 |
MA0147.1 | 0.284471 |
MA0148.1 | 0.425644 |
MA0149.1 | 0.153304 |
MA0062.2 | 0.0491752 |
MA0035.2 | 0.479916 |
MA0039.2 | 0.00190407 |
MA0138.2 | 0.253407 |
MA0002.2 | 0.330883 |
MA0137.2 | 0.206545 |
MA0104.2 | 0.183272 |
MA0047.2 | 0.59341 |
MA0112.2 | 1.34886 |
MA0065.2 | 0.0190901 |
MA0150.1 | 0.605252 |
MA0151.1 | 0 |
MA0152.1 | 0.491228 |
MA0153.1 | 0.553438 |
MA0154.1 | 0.283504 |
MA0155.1 | 0.396018 |
MA0156.1 | 0.458984 |
MA0157.1 | 0.286356 |
MA0158.1 | 0 |
MA0159.1 | 0.0287576 |
MA0160.1 | 0.448616 |
MA0161.1 | 0 |
MA0162.1 | 0.000113447 |
MA0163.1 | 0.0080283 |
MA0164.1 | 0.23445 |
MA0080.2 | 0.184213 |
MA0018.2 | 0.215022 |
MA0099.2 | 0.16368 |
MA0079.2 | 5.17791e-07 |
MA0102.2 | 0.967149 |
MA0258.1 | 0.688105 |
MA0259.1 | 0.126633 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.